Press-room / Digest

The discovery of four genes of the Noggin family in lampreys is consistent with the hypothesis of two rounds of genomic duplications in vertebrate ancestors
Researchers from the Laboratory of Molecular Bases of Embryogenesis, together with a colleague from the Severtsov Institute of Ecology and Evolution, described for the first time four genes of the Noggin family in the oldest representatives of vertebrates - lampreys, and compared their structure, expression and some functional features with those of the known genes of this family in other vertebrates. As a result, it was concluded that the entire set of the data obtained is in the best agreement with the hypothesis of two successive rounds of duplications of the ancestral genome of invertebrates that occurred at the earliest stage of vertebrate evolution. The work was published in the new journal of Nature Publishing Group - Communications Biology. Learn more

A versatile platform for bioimaging based on colominic acid-decorated upconversion nanoparticles
An advanced noninvasive method for bioimaging lesion is fluorescence diagnostics using nanoparticles. Lanthanide-doped upconversion nanoparticles (UCNPs) are promising bioimaging agents that emit light under near infra-red excitation, capable of deep penetrating in biotissues with a high signal-to-noise ratio. However, their successful implementation is principally associated with surface functionalization with biopolymers. Scientists from the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Federal Scientific Research Centre “Crystallography and Photonics”, FSBSI “N.N. Blokhin Russian Cancer Research Center”, Lomonosov Moscow State University of Fine Chemical Technologies and Sechenov First Moscow State Medical University developed a method for the UCNP surface functionalization with endogenous colominic acid conferring “stealth” properties, which led to effective accumulation in the area of inflammation, as well as micro- and macro-blood vessels visualization. The research was published in the journal Biomaterials Science. Learn more

Toxin from black mamba venom inhibits growth of glioma cells selectively expressing ASIC1a channels
The researchers from the IBCh RAS together with the collaborators from the Institute of Cytology RAS demonstrated for the first time the expression of functionally active ASIC1a channels in U251 MG and A172 gliomas cells, but not in normal astrocytes. A recombinant analogue of mambalgin-2 from black mamba venom was used to suppress the cation influx through ASIC1a channels in glioma cells. As it turned out, mambalgin-2 inhibits the growth of gliomas with EC 50 in the nanomolar range, while not affecting the proliferation of normal astrocytes. Mutant variants of mambalgin-2 with impaired affinity for ASIC1a did not affect the proliferation of glioma cells. It was shown that the decrease in the growth of gliomas cells using mambalgin-2 is associated with the cell cycle arrest, inhibition of phosphorylation of cyclin D1 and cyclin-dependent kinases, and apoptosis induction. The study was published in the Cancers journal under support of the Russian Foundation for Basic Research. Learn more

Start codon context and occurrence of AUG codons in the beginning of protein coding open reading frames co-evolve
Researchers from IBCh RAS together with their international collаborators discovered an evolutionary link between efficiency of start codons and the probability of AUG codon occurrence in the 5'-end parts of protein-coding sequences. When start codons are inefficient the next AUG codon is more likely to be found in the same reading frame. At the same time in case of highly efficient start codons, the next AUG codon is more likely to be found in alternative frames. They also have shown that weak initiation at the first starts is associated with the synthesis of shortened proteoforms as a result of initiation at the second starts. The study was published in the journal Genome Research. Learn more

New technology promises to revolutionize nanomedicine
A collaboration of scientists from the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, the Moscow Institute of Physics and Technology and Prokhorov General Physics Institute of the Russian Academy of Sciences have developed a breakthrough technology to resolve a key problem that has prevented the introduction of novel drugs into clinical practice for decades. The new solution prolongs blood circulation for virtually any nanomedicine, boosting its therapeutic efficiency. The study was published in Nature Biomedical Engineering and featured in the journal’s News & Views section. Learn more